We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SLN market cap is 2.36B. The company's latest EPS is GBP -0.3756 and P/E is -21.30.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 3.64M | 3.37M | 4.77M | 11.37M | 9.1M |
Operating Income | -14.21M | -13.62M | -10.96M | -12.07M | -11.15M |
Net Income | -11.94M | -7.1M | -13.76M | -10.2M | -10.4M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 244k | 5.48M | 12.42M | 17.5M |
Operating Income | -20.57M | -22.73M | -32.48M | -45.81M | -48.59M |
Net Income | -18.41M | -19.58M | -32.55M | -39.41M | -40.49M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 83.4M | 124.04M | 107.5M | 94.34M | 92.71M |
Total Liabilities | 88.14M | 89.91M | 85.43M | 77.75M | 80.46M |
Total Equity | -4.74M | 34.13M | 22.07M | 16.59M | 12.26M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 38.89M | 46.08M | 85.97M | 96.19M | 107.5M |
Total Liabilities | 3.83M | 25.17M | 76.91M | 87.67M | 85.43M |
Total Equity | 35.06M | 20.91M | 9.06M | 8.53M | 22.07M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -22.64M | N/A | -45.46M | -7.66M | -22.61M |
Investing | -86k | N/A | -16.54M | 128k | -4.58M |
Financing | -58k | N/A | 43.05M | 19k | 3.2M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -16.76M | 1.73M | -10.78M | 6.81M | -45.46M |
Investing | -4.83M | -15.02M | 9.62M | 8.68M | -16.54M |
Financing | 341k | 5.27M | 15.43M | 30.71M | 43.05M |
Market Cap | 2.36B |
Price to Earnings Ratio | -21.30 |
Price to Sales Ratio | 49.29 |
Price to Cash Ratio | 15.73 |
Price to Book Ratio | 39.08 |
Dividend Yield | - |
Shares Outstanding | 107.81M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 3.23 (13.61%) |
Company Name | Silence Therapeutics PLC |
Address |
27 eastcastle street london W1W 8DH |
Website | https://www.silence-therapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions